Willem A. Bax
Alkmaar, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease: FLOW Trial Cardiovascular Subgroup Analyses.
Journal: Journal of the American College of Cardiology
Published: September 26, 2025
Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis: An Exploratory Substudy of the LoDoCo2 Trial.
Journal: Journal of the American College of Cardiology
Published: July 24, 2025
Colchicine Alleviates Non-Atherosclerotic Vascular Aging by Targeting Endothelial Dysfunction and Inflammatory Status.
Journal: Journal of inflammation research
Published: June 03, 2025
Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial.
Journal: Journal of the American Heart Association
Published: May 15, 2025
Interleukin-6 modifies Lipoprotein(a) and oxidized phospholipids associated cardiovascular disease risk in a secondary prevention cohort.
Journal: Atherosclerosis
Published: November 06, 2024
The effects of colchicine on lipoprotein(a)- and oxidized phospholipid-associated cardiovascular disease risk.
Journal: European journal of preventive cardiology
Published: August 22, 2024
Identifying persistent high-cost patients in the hospital for care management: development and validation of prediction models.
Journal: BMC health services research
Published: August 02, 2024
Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia.
Journal: European journal of preventive cardiology
Published: October 30, 2023
Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial.
Journal: Frontiers in cardiovascular medicine
Published: June 22, 2023
An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk.
Journal: Clinical therapeutics
Published: May 01, 2023
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial.
Journal: Clinical drug investigation
Published: September 26, 2022
Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial.
Journal: International journal of cardiology
Published: September 14, 2022
Last Updated: 09/26/2026